Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+90.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+90.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.9x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.56M | +15.1% |
| 2024 | $7.43M | +250.8% |
| 2023 | $2.12M | +72.0% |
| 2022 | $1.23M | +8113.3% |
| 2021 | $15000.00 | +102.7% |
| 2020 | $-565000.00 | - |